Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nielsen Survey Finds China Consumers Most Concerned About Drugs’ Credibility

This article was originally published in PharmAsia News

Executive Summary

According to a recent worldwide online survey jointly conducted by Nielsen Company and the Association of the European Self-Medication Industry, more than 30 percent of China consumers indicate they would self-medicate for minor ailments such as headache, cold and dyspepsia. They consider credibility, safety and effectiveness as the three most important criteria for OTC drugs. Nearly two-thirds of respondents prefer to take medicine only if they do not get well naturally after some time, while two percent say they never take medicine. Almost 70 percent of these two groups attribute their avoidance of medicine to the perception of drug toxicity. When selecting prescription drugs, close to half of China respondents said that a trustworthy brand is the most important factor. Such concern is also the highest in the global survey. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel